TITLE

Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials

AUTHOR(S)
Zarychanski, Ryan; Turgeon, Alexis F.; McIntyre, Lauralyn; Fergusson, Dean A.
PUB. DATE
September 2007
SOURCE
CMAJ: Canadian Medical Association Journal;9/25/2007, Vol. 177 Issue 7, p725
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction: Anemia and the need for red blood cell transfusions are common among patients admitted to intensive care units. Erythropoietin has been used to decrease the need for transfusions; however, its ability to improve clinical outcomes is unknown. We evaluated the effect of erythropoietinreceptor agonists on clinically important outcomes, including mortality, length of stay in hospital or intensive care unit, ventilator use, transfusion requirements and major adverse events. Methods: To identify relevant studies, we searched electronic databases covering 1950 to 2007 (MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials and the Scopus database). We also searched conference proceedings and grey literature sources. We selected all randomized controlled trials involving critically ill patients that compared an erythropoietin-receptor agonist with a placebo or no intervention. No language restrictions were considered. Data were extracted using a standardized extraction template. We used a fixed effects model to calculate all summary measures of treatment effects. Results: Of 673 identified records, 9 studies that investigated erythropoietin alpha met the eligibility criteria and were included in our analysis. Erythropoietin, compared with placebo or no intervention, had no statistically significant effect on overall mortality (odds ratio [OR] 0.86, 95% confidence interval [CI] 0.71-1.05, I² = 0%). The treatment and control groups did not differ in the length of stay in hospital or intensive care unit, or in the duration of mechanical ventilation, in the 3 studies that reported these outcomes. Erythropoietin, compared with placebo, significantly reduced the odds of a patient receiving at least 1 transfusion (OR 0.73, 95% CI 0.64-0.84, I² = 54.7%). The mean number of units of blood transfused per patient was decreased by 0.41 units in the erythropoietin group (95% CI 0.10-0.74, I² = 79.2%). Most of the included studies were performed before the widespread adoption of a restrictive transfusion strategy. Only 1 study provided detailed reports of adverse events, and none of the studies systematically evaluated all patients for venous thromboembolism. Interpretation: At this time, we do not recommend the routine use of erythropoietin-receptor agonists in critically ill patients. The reduction in red blood cell transfusions per patient was very small, and there is insufficient evidence to determine whether this intervention results in clinically important benefits with acceptable risks.
ACCESSION #
26594455

 

Related Articles

  • Blood conservation strategies to reduce the need for red blood cell transfusion in critically ill patients. Tinmouth, Alan T.; McIntyre, Lauralynn A.; Fowler, Robert A. // CMAJ: Canadian Medical Association Journal;1/1/2008, Vol. 178 Issue 1, p49 

    Anemia commonly affects critically ill patients. The causes are multifactorial and include acute blood loss, blood loss from diagnostic testing and blunted red blood cell production. Blood transfusions are frequently given to patients in intensive care units to treat low hemoglobin levels due to...

  • Red Blood Cell Transfusion in the Neurological ICU. Kumar, Monisha // Neurotherapeutics;Jan2012, Vol. 9 Issue 1, p56 

    Red blood cell transfusion (RBCT) is a common therapy used in the intensive care unit to treat anemia. However, due to deleterious side effects and questionable efficacy, the clinical benefit of RBCT in patients who are not actively bleeding is unclear. The results of randomized controlled...

  • An Epidemiological Study of Anemia and Renal Dysfunction in Patients Admitted to ICUs across the United States. Brophy, Donald F.; Harpe, Spencer E.; Carl, Daniel E.; Brophy, Gretchen M. // Anemia (20901267);2012, p1 

    The aims of this study were to determine the associations between anemia of critical illness, erythropoietin stimulating agents (ESA), packed red blood cell transfusions and varying degrees of renal dysfunction with mortality, and ICU- and hospital length of stay (LOS). This was a...

  • Co-enrollment of critically ill patients into multiple studies: patterns, predictors and consequences. Cook, Deborah; McDonald, Ellen; Smith, Orla; Zytaruk, Nicole; Heels-Ansdell, Diane; Watpool, Irene; McArdle, Tracy; Matte, Andrea; Clarke, France; Vallance, Shirley; Finfer, Simon; Galt, Pauline; Crozier, Tim; Fowler, Rob; Arabi, Yaseen; Woolfe, Clive; Orford, Neil; Hall, Richard; Adhikari, Neill K.J.; Ferland, Marie-Clauide // Critical Care;2013, Vol. 17 Issue 1, p1 

    Introduction: Research on co-enrollment practices and their impact are limited in the ICU setting. The objectives of this study were: 1) to describe patterns and predictors of co-enrollment of patients in a thromboprophylaxis trial, and 2) to examine the consequences of co-enrollment on clinical...

  • Management of epoetin alpha use in the intensive care unit: a drug use evaluation. Quercia, Robert A.; Udeh, Elizabeth; Keating, Kevin E.; Sherburne, Bradford; Goldman, Monica C. // Formulary;Sep2006, Vol. 41 Issue 9, p442 

    This study evaluates the appropriateness and cost implications of using epoetin alpha for transfusion reduction in Hartford Hospital's (Hartford, Conn) intensive care units (ICUs), with the goal of implementing a protocol for use in this setting. We conducted a literature review to determine the...

  • Effect of a blood conservation device in patients with preserved admission haemoglobin in the intensive care unit. MUKHOPADHYAY, A.; SEE, K. C.; CHAN, Y. H.; YIP, H. S.; PHUA, J. // Anaesthesia & Intensive Care;May2011, Vol. 39 Issue 3, p426 

    The article discusses the results of a study which investigates the benefits of using a closed system blood conservation device in patients with preserved level of hemoglobin on admission to the intensive care unit (ICU). According to the authors, the use of the device does not result to a...

  • Red blood cell transfusion in non-bleeding critically ill patients with moderate anemia: is there a benefit? Leal-Noval, Santiago; Muñoz-Gómez, Manuel; Jiménez-Sánchez, Mercedes; Cayuela, Aurelio; Leal-Romero, María; Puppo-Moreno, Antonio; Enamorado, Judy; Arellano-Orden, Victoria // Intensive Care Medicine;Mar2013, Vol. 39 Issue 3, p445 

    Purpose: This study was undertaken to investigate the efficacy of red blood cell transfusion (RBCT) at reversing the deleterious effects of moderate anemia in critically ill, non-bleeding patients. Methods: This was a retrospective, pair-matched (ratio 1:1) cohort study. Non-bleeding critically...

  • Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung injury to Reduce Pulmonary dysfunction (HARP-2) trial: study protocol for a randomized controlled trial. McAuley, Daniel F.; Laffey, John G.; O¨Kane, Cecilia M.; Cross, Mark; Perkins, Gavin D.; Murphy, Lynn; McNally, Christine; Crealey, Grainne; Stevenson, Michael // Trials;2012, Vol. 13 Issue 1, p170 

    Background: Acute lung injury (ALI) is a common devastating clinical syndrome characterized by life-threatening respiratory failure requiring mechanical ventilation and multiple organ failure. There are in vitro, animal studies and pre-clinical data suggesting that statins may be beneficial in...

  • Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial. Barraud, Damien; Blard, Claire; Hein, François; Marçon, Olivier; Cravoisy, Aurélie; Nace, Lionel; Alla, François; Bollaert, Pierre-Edouard; Gibot, Sébastien // Intensive Care Medicine;Sep2010, Vol. 36 Issue 9, p1540 

    Probiotics have been shown to be able to restore a non-pathogenic digestive flora, to prevent digestive colonization by pathogenic bacteria, and to modulate immunity. The aim of this study was to assess the effects of prophylactic probiotic administration in patients ventilated for up to 2 days....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics